Khurum Khan

Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer

Andrew Woolston, Khurum Khan, Georgia Spain et al. · Cancer Cell · 2019 · 254 citations · Full text

Tumor Biology, Cetuximab Resistance Landscape, Immune Landscape Evolution +13

Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

Sheela Rao, Marianne G. Guren, Khurum Khan et al. · Annals of Oncology · 2021 · 230 citations

Surgical Oncology, Esophageal Cancer, Gastrointestinal Oncology +6

CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids

Reyes Gonzalez-Exposito, Maria Semiannikova, B Griffiths et al. · Journal for ImmunoTherapy of Cancer · 2019 · 110 citations · Full text

Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Management

Khurum Khan, Mabel Wong, Karim Rihawi et al. · The Oncologist · 2016 · 62 citations · Full text

Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): The Royal Marsden Hospital (RMH) experience

Khurum Khan, Clare Peckitt, Francesco Sclafani et al. · BMC Cancer · 2015 · 46 citations · Full text